title: Response to "Comment on 'AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137'" [Med. Phys. 36, 5310-5322 (2009)].
authors.forename: Ravinder
authors.initials: R
authors.lastname: Nath
authors.forename: William S
authors.initials: WS
authors.lastname: Bice
authors.forename: Wayne M
authors.initials: WM
authors.lastname: Butler
authors.forename: Zhe
authors.initials: Z
authors.lastname: Chen
authors.forename: Ali S
authors.initials: AS
authors.lastname: Meigooni
authors.forename: Vrinda
authors.initials: V
authors.lastname: Narayana
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Rivard
authors.forename: Yan
authors.initials: Y
authors.lastname: Yu
mesh_terms: D000465:Algorithms; D001918:Brachytherapy / Q000379:methods*; D002588:Cesium Radioisotopes / Q000494:pharmacology; D006801:Humans; D007457:Iodine Radioisotopes / Q000494:pharmacology; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D010165:Palladium / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000494:pharmacology; D011874:Radiometry / Q000379:methods; D011879:Radiotherapy Dosage; D013997:Time Factors; D014057:Tomography, X-Ray Computed / Q000379:methods
chemical_list: D002588:Cesium Radioisotopes; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium